5.71 -0.11 (-1.89%) | 05-17 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 10.46 | 1-year : | 13.75 |
Resists | First : | 8.96 | Second : | 11.77 |
Pivot price | 6.22 | |||
Supports | First : | 4.4 | Second : | 3.66 |
MAs | MA(5) : | 5.97 | MA(20) : | 6.36 |
MA(100) : | 0 | MA(250) : | 0 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 33.6 | D(3) : | 39.4 |
RSI | RSI(14): 45.5 | |||
52-week | High : | 8.39 | Low : | 4.4 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TRSG ] has closed above bottom band by 26.6%. Bollinger Bands are 0% narrower than normal.
If tomorrow: | Open lower | Open higher |
High: | 5.95 - 5.99 | 5.99 - 6.03 |
Low: | 5.48 - 5.53 | 5.53 - 5.57 |
Close: | 5.64 - 5.72 | 5.72 - 5.78 |
Tue, 30 Apr 2024
Tungray Technologies secures additional $5.41 million in IPO By Investing.com - Investing.com
Tue, 23 Apr 2024
Tungray Technologies completes $5M initial public offering By Investing.com - Investing.com
Tue, 23 Apr 2024
Tungray Technologies Closes $5M IPO - Investing.com India
Mon, 22 Apr 2024
Opening Day: Ibotta soars in strong market debut - TipRanks.com - TipRanks
Mon, 22 Apr 2024
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Se - Benzinga
Fri, 19 Apr 2024
Tungray Technologies Prices 1.25M Share IPO at $4/sh By Investing.com - Investing.com
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 12 (M) |
Shares Float | 3 (M) |
Held by Insiders | 79.1 (%) |
Held by Institutions | 0 (%) |
Shares Short | 48 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 1.09 |
Profit Margin | 6.3 % |
Operating Margin | 11.1 % |
Return on Assets (ttm) | 2.6 % |
Return on Equity (ttm) | 5.1 % |
Qtrly Rev. Growth | 14.6 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 1.21 |
EBITDA (p.s.) | 0.11 |
Qtrly Earnings Growth | -47.6 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -1 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 5.23 |
Price to Sales | 4.68 |
Price to Cash Flow | 149.26 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |